Tirzepatide, marketed as mounjaro and recently also as zepbound specifically for weight management, was approved for type 2 diabetes in 2022 and for weight management in 2023. It’s an injection you take once every seven days. Learn about dosing, side effects, warnings, and who is eligible.
[10] the most common side effects include nausea, vomiting, diarrhea, decreased appetite, constipation, upper abdominal discomfort, and abdominal pain It also helps with weight loss This guide shows what to expect each month — from side effects to weight loss milestones.
It is used together with diet and exercise to help control your blood sugar Mounjaro (tirzepatide) helps manage blood sugar in people with type 2 diabetes
